We do not source or recommend research-only products sold for human use.Our safety stance →

Telehealth for Miami

Telehealth GLP-1, HRT & Peptides for Women in Miami

Women in Miami can see a Dominia Health provider online about medical weight loss with GLP-1 medications, menopause and hormone care, and peptides. If something is prescribed, it ships to you. Compounded GLP-1s are not FDA-approved and are not brand-name drugs. Telehealth for Miami residents only, with no Miami office. We serve all 50 states.

Care that fits a Miami schedule

Between work, family and traffic, a clinic visit can take a whole morning. The U.S. Census Bureau estimates the average Miami commute at roughly 27.3 minutes each way (QuickFacts, 2020–2024). A Dominia consultation happens over secure video, so you can join from home, the office or wherever you have privacy.

During the visit a licensed provider goes through your health history, current medications, cycle or menopause symptoms and goals, then explains whether a treatment is reasonable and why. Follow-up check-ins and prescription renewals are online too.

Heat, deliveries and the FDA's storage advice

South Florida heat is hard on packages. The FDA says injectable GLP-1 drugs need refrigeration and recommends not using any that arrive warm or with too few ice packs. If your box feels warm or the cold packs have fully melted, set it aside and message your care team.

The FDA also advises that multi-dose vials of sterile injectables generally be discarded 28 days after first use, even if medicine remains, and that you use a new sterile needle and syringe every time. Ask your provider how this applies to your prescription.

Weight loss, hormones and peptides, honestly

Among the options we discuss, GLP-1 medications such as semaglutide and tirzepatide have the most trial evidence, from studies of the FDA-approved versions. Compounded semaglutide is not Ozempic® or Wegovy®, or a generic of either; compounded tirzepatide is not Mounjaro® or Zepbound®, or a generic of either. They are prepared for an individual prescription by a licensed 503A/503B compounding pharmacy.

For perimenopause and menopause, options can include estradiol, progesterone and, off-label, low-dose testosterone. Compounded hormones are not FDA-approved. Peptide therapies have thinner evidence, and compounded versions are not FDA-approved.

[We do not source or recommend research-only products sold for human use.](https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss)

Labs in Miami

Hormone therapy usually needs recent labs; GLP-1 plans often do not at the start. When labs are ordered, you visit an independent lab, never a Dominia office. Quest Diagnostics and Labcorp each list several Miami patient service centers (Quest, Labcorp; checked October 2026).

Who is behind Dominia

Dominia Health's co-founders include registered nurses Ana Argote, BSN, R.N., and Ariel Bowerman, BSN, R.N. Treatment decisions are made by the licensed provider who evaluates you.

FAQ

Frequently asked questions

Ready to talk it through?

Telehealth for Miami residents. We serve all 50 states.

Book Your Consultation

Important medical disclaimer

Dominia Health is a telehealth service for women. A licensed provider decides whether any treatment fits you after reviewing your health history, and not everyone is a candidate. Compounded medications are not FDA-approved; the FDA does not review them for safety, effectiveness or quality before they are marketed. Compounded semaglutide is not Ozempic® or Wegovy®, or a generic of either. Compounded tirzepatide is not Mounjaro® or Zepbound®, or a generic of either. Results vary and are not guaranteed. This page is general education, not medical advice, and it does not create a provider-patient relationship. In an emergency, call 911.

Important Medical & Compounded Medication Disclaimer

Dominia Health provides telehealth consultations and may prescribe compounded medications, including compounded Semaglutide and compounded Tirzepatide, when clinically appropriate.

Compounded medications are not FDA-approved. The U.S. Food and Drug Administration (FDA) does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded Semaglutide and Tirzepatide are prepared by state-licensed compounding pharmacies pursuant to individual patient prescriptions and are not the same as, or generic equivalents of, FDA-approved brand-name medications such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.

These compounded formulations are prescribed only after a licensed healthcare provider evaluates your individual medical history, health goals, and eligibility through a telehealth consultation. Not everyone is a candidate for treatment.

Results vary from person to person and are not guaranteed. Weight loss and other outcomes depend on many factors, including individual biology, adherence to the prescribed plan, lifestyle, and ongoing medical supervision. Any testimonials or patient stories shown on this website are illustrative of individual experiences and do not guarantee similar results.

The information on this website is for general educational purposes only and is not medical advice. It does not create a doctor-patient relationship. Always consult a qualified healthcare provider for personalized medical advice, diagnosis, or treatment decisions.

By using this website or requesting a consultation, you acknowledge that you understand the above statements regarding compounded medications and telehealth services.

© 2026 Dominia Health. All rights reserved.

Sister brand: Scoreboard Health (men's telehealth)

Medical Disclaimer: Dominia Health provides telehealth services. All treatments are prescribed by licensed medical providers. Results vary by individual.